Finnish study confirms safety of MMR vaccineBMJ 2001; 322 doi: https://doi.org/10.1136/bmj.322.7279.129/b (Published 20 January 2001) Cite this as: BMJ 2001;322:129
View Full Text
- Jacqui Wise
A large prospective follow up of the measles, mumps, and rubella (MMR) vaccination programme in Finland has concluded that serious adverse events are rare and greatly outweighed by the risks of disease. The message is reinforced by two independent advisory bodies in the United Kingdom, which have carried out further reviews of the safety data.
The Committee on Safety of Medicines and the Joint Committee on Vaccination and Immunisation independently examined all the data in an …
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.